Published Date：Mar.2021
Industry：Pharma & Healthcare
Pages：105 Table Number：124
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Infantile Spasms Therapeutics market in this environment. In terms of revenue, this research report indicated that the global Infantile Spasms Therapeutics market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Infantile Spasms Therapeutics industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The H. Lundbeck aims at producing XX K Units Infantile Spasms Therapeutics in 2020, with XX % production to take place in global market, Mallinckrodt accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Infantile Spasms Therapeutics Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Infantile Spasms Therapeutics Market? H. Lundbeck Mallinckrodt Insys Therapeutics Orphelia Pharma Valerion Therapeutics Catalyst Pharmaceuticals Anavex Life Sciences Retrophin ... Major Type of Infantile Spasms Therapeutics Covered in XYZResearch report: Oral Injection Application Segments Covered in XYZResearch Market Hospital Clinic Others For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Infantile Spasms Therapeutics Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Oral -Product Introduction and Major Manufacturers 1.1.2 Injection -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Infantile Spasms Therapeutics Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Infantile Spasms Therapeutics Market 3.1.1 Top Companies leading Infantile Spasms Therapeutics Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Infantile Spasms Therapeutics Market 3.2.1 Top Companies leading Infantile Spasms Therapeutics Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Infantile Spasms Therapeutics Market 3.3.1 Top Companies leading Infantile Spasms Therapeutics Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Infantile Spasms Therapeutics Market 3.4.1 Top Companies leading Infantile Spasms Therapeutics Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Infantile Spasms Therapeutics Market 3.5.1 Top Companies leading Infantile Spasms Therapeutics Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Infantile Spasms Therapeutics Market 3.6.1 Top Companies leading Infantile Spasms Therapeutics Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Infantile Spasms Therapeutics Market 3.7.1 Top Companies leading Infantile Spasms Therapeutics Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Infantile Spasms Therapeutics Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Infantile Spasms Therapeutics Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Infantile Spasms Therapeutics Sales and Growth Rate (2021-2027) 5.2 Global Infantile Spasms Therapeutics Sales Value and Growth Rate (2021-2027) 6 Infantile Spasms Therapeutics Competitive Analysis 6.1 H. Lundbeck 6.1.1 H. Lundbeck Company Profiles 6.1.2 H. Lundbeck Product Introduction 6.1.3 H. Lundbeck Infantile Spasms Therapeutics Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 Mallinckrodt 6.2.1 Mallinckrodt Company Profiles 6.2.2 Mallinckrodt Product Introduction 6.2.3 Mallinckrodt Infantile Spasms Therapeutics Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Insys Therapeutics 6.3.1 Insys Therapeutics Company Profiles 6.3.2 Insys Therapeutics Product Introduction 6.3.3 Insys Therapeutics Infantile Spasms Therapeutics Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Orphelia Pharma 6.4.1 Orphelia Pharma Company Profiles 6.4.2 Orphelia Pharma Product Introduction 6.4.3 Orphelia Pharma Infantile Spasms Therapeutics Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 Valerion Therapeutics 6.5.1 Valerion Therapeutics Company Profiles 6.5.2 Valerion Therapeutics Product Introduction 6.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 Catalyst Pharmaceuticals 6.6.1 Catalyst Pharmaceuticals Company Profiles 6.6.2 Catalyst Pharmaceuticals Product Introduction 6.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 6.7 Anavex Life Sciences 6.7.1 Anavex Life Sciences Company Profiles 6.7.2 Anavex Life Sciences Product Introduction 6.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Production, Revenue (2016-2021) 6.7.4 SWOT Analysis 6.8 Retrophin 6.8.1 Retrophin Company Profiles 6.8.2 Retrophin Product Introduction 6.8.3 Retrophin Infantile Spasms Therapeutics Production, Revenue (2016-2021) 6.8.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Infantile Spasms Therapeutics Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Infantile Spasms Therapeutics Sales (K Unit) by Type (2026-2027) Figure Global Infantile Spasms Therapeutics Sales (K Unit) and Growth Rate (2026-2027) Figure Global Infantile Spasms Therapeutics Sales Market Share (%) by Type (2019 -2020) Table Global Infantile Spasms Therapeutics Sales Value (Million USD) by Type (2026-2027) Figure Global Infantile Spasms Therapeutics Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Infantile Spasms Therapeutics Sales Value Market Share (%) by Type (2019-2020) Table Global Infantile Spasms Therapeutics Sales (K Unit) by Application (2026-2027) Table China Infantile Spasms Therapeutics Sales (K Unit) of Major Company (2016-2021) Table China Infantile Spasms Therapeutics Sales Market Share of Major Company (2016-2021) Table China Infantile Spasms Therapeutics Sales Value (Million USD) of Major Company (2016-2021) Figure China Infantile Spasms Therapeutics Sales Value (Million USD) and Growth Rate (2016-2021) Table China Infantile Spasms Therapeutics Sales Value Share of Major Company (2016-2021) Table China Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) Table China Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Figure China Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Table EU Infantile Spasms Therapeutics Sales (K Unit) of Major Company (2016-2021) Table EU Infantile Spasms Therapeutics Sales Market Share of Major Company (2016-2021) Table EU Infantile Spasms Therapeutics Sales Value (Million USD) of Major Company (2016-2021) Figure EU Infantile Spasms Therapeutics Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Infantile Spasms Therapeutics Sales Value Share of Major Company (2016-2021) Table EU Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) Table EU Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Figure EU Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Table USA Infantile Spasms Therapeutics Sales (K Unit) of Major Company (2016-2021) Table USA Infantile Spasms Therapeutics Sales Market Share of Major Company (2016-2021) Table USA Infantile Spasms Therapeutics Sales Value (Million USD) of Major Company (2016-2021) Figure USA Infantile Spasms Therapeutics Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Infantile Spasms Therapeutics Sales Value Share of Major Company (2016-2021) Table USA Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) Table USA Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Figure USA Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Table Japan Infantile Spasms Therapeutics Sales (K Unit) of Major Company (2016-2021) Table Japan Infantile Spasms Therapeutics Sales Market Share of Major Company (2016-2021) Table Japan Infantile Spasms Therapeutics Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Infantile Spasms Therapeutics Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Infantile Spasms Therapeutics Sales Value Share of Major Company (2016-2021) Table Japan Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) Table Japan Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Figure Japan Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Table India Infantile Spasms Therapeutics Sales (K Unit) of Major Company (2016-2021) Table India Infantile Spasms Therapeutics Sales Market Share of Major Company (2016-2021) Table India Infantile Spasms Therapeutics Sales Value (Million USD) of Major Company (2016-2021) Figure India Infantile Spasms Therapeutics Sales Value (Million USD) and Growth Rate (2016-2021) Table India Infantile Spasms Therapeutics Sales Value Share of Major Company (2016-2021) Table India Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) Table India Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Figure India Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Table Southeast Asia Infantile Spasms Therapeutics Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Infantile Spasms Therapeutics Sales Market Share of Major Company (2016-2021) Table Southeast Asia Infantile Spasms Therapeutics Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Infantile Spasms Therapeutics Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Infantile Spasms Therapeutics Sales Value Share of Major Company (2016-2021) Table Southeast Asia Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Figure Southeast Asia Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Table South America Infantile Spasms Therapeutics Sales (K Unit) of Major Company (2016-2021) Table South America Infantile Spasms Therapeutics Sales Market Share of Major Company (2016-2021) Table South America Infantile Spasms Therapeutics Sales Value (Million USD) of Major Company (2016-2021) Figure South America Infantile Spasms Therapeutics Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Infantile Spasms Therapeutics Sales Value Share of Major Company (2016-2021) Table South America Infantile Spasms Therapeutics Price (USD/Unit), by Type (2019-2020) Table South America Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Figure South America Infantile Spasms Therapeutics Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Infantile Spasms Therapeutics Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Infantile Spasms Therapeutics Figure Cost Structure of Infantile Spasms Therapeutics in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Infantile Spasms Therapeutics Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Infantile Spasms Therapeutics Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table H. Lundbeck Profiles Table H. Lundbeck Infantile Spasms Therapeutics Product Introduction Table H. Lundbeck Infantile Spasms Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure H. Lundbeck SWOT Analysis Table Mallinckrodt Profiles Table Mallinckrodt Infantile Spasms Therapeutics Product Introduction Table Mallinckrodt Infantile Spasms Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Mallinckrodt SWOT Analysis Table Insys Therapeutics Profiles Table Insys Therapeutics Infantile Spasms Therapeutics Product Introduction Table Insys Therapeutics Infantile Spasms Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Insys Therapeutics SWOT Analysis Table Orphelia Pharma Profiles Table Orphelia Pharma Infantile Spasms Therapeutics Product Introduction Table Orphelia Pharma Infantile Spasms Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Orphelia Pharma SWOT Analysis Table Valerion Therapeutics Profiles Table Valerion Therapeutics Infantile Spasms Therapeutics Product Introduction Table Valerion Therapeutics Infantile Spasms Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Valerion Therapeutics SWOT Analysis Table Catalyst Pharmaceuticals Profiles Table Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product Introduction Table Catalyst Pharmaceuticals Infantile Spasms Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Catalyst Pharmaceuticals SWOT Analysis Table Anavex Life Sciences Profiles Table Anavex Life Sciences Infantile Spasms Therapeutics Product Introduction Table Anavex Life Sciences Infantile Spasms Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Anavex Life Sciences SWOT Analysis Table Retrophin Profiles Table Retrophin Infantile Spasms Therapeutics Product Introduction Table Retrophin Infantile Spasms Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
